Sulfotransferase 2B1 pharmacogenetics

Details Sulfotransferase 2B1 pharmacogenetics Sulfotransferase 2B1 pharmacogenetics

2007-09-25

2010-10-26

Bausch, Sarae (Department: 1634)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024300, C435S091100, C435S091200, C435S006120

Reexamination Certificate

active

07820805

ABSTRACT:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as are sulfotransferase allozymes. Methods for determining the sulfonator status of a subject also are described. In addition, methods for predicting the therapeutic efficacy of a compound in a subject are described, as are methods for estimating the dose of a compound to be administered to a subject.

REFERENCES:
patent: 5541308 (1996-07-01), Hogan et al.
patent: 5733729 (1998-03-01), Lipshutz et al.
patent: 5770722 (1998-06-01), Lockhart et al.
patent: 6110709 (2000-08-01), Ausubel et al.
patent: 6242244 (2001-06-01), Donohue et al.
patent: 6747137 (2004-06-01), Weinstock et al.
patent: 2001/0036632 (2001-11-01), Yu et al.
patent: 2003/0084474 (2003-05-01), Sung et al.
patent: 2009/0093620 (2009-04-01), Kovalic et al.
patent: WO 02/68579 (2002-06-01), None
Campbell et al., “Human Liver Phenol Sulfotransferase: Assay Conditions, Biochemical Properties and Partial Purification of Isozymes of the Thermostable Form,”Biochem. Pharmacol., 1987, 36(9):1435-1446.
Chin, “On the preparation and utilization of isolated and purified oligonucleotides,” University of North Carolina, Mar. 9, 2002.
Cibelli et al., “Cloned Transgenic Calves Produced from Nonquiescent Fetal Fibroblasts,”Science, 1998, 280:1256-1258.
Cleland, “Computer Programmes for Processing Enzyme Kinetic Data,”Enzyme, 1963, 198:463-465.
Cole et al., “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,”Monoclonal Antibodies and Cancer Therapy, 1985, Alan R. Liss, Inc., pp. 77-96.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci. USA, 1983, 80:2026-2030.
Excoffier and Slatkin, “Maximum-Likelihood Estimation of Molecular Haplotype Frequencies in a Diploid Population,”Mol. Biol. Evol., 1995, 12(5):921-927.
Guatelli et al., “Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication,”Proc. Natl. Acad. Sci. USA, 1990, 87:1874-1878.
Hacia et al., “Detection of heterozygous mutations inBRCA1using high density oligonucleotide arrays and two-colour fluorescence analysis,”Nature Genet., 1996, 14:441-447.
Halushka et al., “Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis,”Nat. Genet., 1999, 22:239-247.
Hartl and Clark, “Chromosomes and Heredity,”Princi ples of Population Genetics, 3rded., 1997, Sinauer Associates, Inc., (Sunderland, MA), pp. 96-106.
Hedrick, “An Introduction to Gametic Disequilibrium,”Genetics of Populations, 2nded., 2000, Jones and Bartlett, (Sudbury, MA), pp. 396-406.
Her et al., “Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene,”Genomics, 1998, 53:284-295.
Ho et al., “Site-directed mutagenesis by overlap extension using the polymerase chain reaction,”Gene, 1989, 77:51-59.
Hyrup and Nielsen, “Peptide Nucleic Acids (PNA): Synthesis, Properties and Potential Applications,”Bioorgan. Med. Chem., 1996, 4(1):5-23.
Iida et al., “Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes,”J. Hum. Genet., 2001, 46:225-240.
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature, 1975, 256:495-497.
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes,”Immunology Today, 1983, 4:72-79.
Lewis, “PCR's Competitors Are Alive and Well and Moving Rapidly Towards Commercialization,”Genetic Engineering News, 1992, vol. 12, 3 pages.
Long et al., “An E-M Algorithm and Testing Strategy for Multiple-Locus Haplotypes,”Am. J. Hum. Genet., 1995, 56:799-810.
Myakishev et al., “High-Throughput SNP Genotyping by Allele-Specific PCR with Universal Energy-Transfer-Labeled Primers,”Genome Res., 2001, 11:163-169.
Prince et al., “Robust and Accurate Single Nucleotide Polymorphism Genotyping by Dynamic Allele-Specific Hybridization (DASH): Design Criteria and Assay Validation,”Genome Res., 2001, 11:152-162.
Schafer and Hawkins, “DNA variation and the future of human genetics,”Nat. Biotechnol., 1998, 16:33-39.
Shastry, “Gene disruption in mice: Models of development and disease,”Mol. Cell Biochem., 1998, 181:163-179.
Stoneking et al., “Population Variation of Human mtDNA Control Region Sequences Detected by Enzymatic Amplification and Sequence-specific Oligonucleotide Probes,”Am. J. Hum. Genet., 1991, 48:370-382.
Summerton and Weller, “Morpholino Antisense Oligomers: Design, Preparation, and Properties,”Antisense Nucleic Acid Drug. Dev., 1997, 7:187-195.
Terwilliger and Ott,Handbook of Human Genetic Linkage, 1994, The Johns Hopkins University Press, Baltimore, pp. 188-193.
Underhill et al., “Detection of Numerous Y Chromosome Biallelic Polymorphisms by Denaturing High-Performance Liquid Chromatography,”Genome Res., 1997, 7:996-1005.
Van Loon and Weinshilboum, “Thiopurine Methyltransferase Isozymes in Human Renal Tissue,”Drug Metab. Dispos., 1990, 18(5):632-638.
Van Loon et al., “Human Kidney Thiopurine Methyltransferase. Photoaffinity Labeling with S-Adenosyl-L-Methionine,”Biochem. Pharmacol., 1992, 44(4):775-785.
Wakayama et al., “Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei,”Nature, 1998, 394:369-374.
Weiss, “Hot Prospect for New Gene Amplifier,”Science, 1991, 254:1292-1293.
Wilkinson, “Statistical Estimations in Enzyme Kinetics,”Biochem. J., 1961, 80:324-332.
Wilmut et al., “Viable offspring derived from fetal and adult mammalian cells,”Nature, 1997, 385:810-813.
Wood et al., “Human Liver Thermolabile Phenol Sulfotransferase: cDNA Cloning, Expression and Characterization,”Biochem. Biophys. Res. Comm., 1994, 198(3):1119-1127.

Affiliated with

Also associated with

Rating

Sulfotransferase 2B1 pharmacogenetics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfotransferase 2B1 pharmacogenetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfotransferase 2B1 pharmacogenetics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4214407